| 國立成功大學 |
2021 |
The association between ivabradine and adverse cardiovascular events in acute decompensated HFrEF patients
|
Liao, C.-T.;Huang, J.-L.;Liang, H.-W.;Chung, F.-P.;Lee, Y.-H.;Lin, P.-L.;Chiou, W.-R.;Lin, W.-Y.;Hsu, C.-Y.;Chang, H.-Y. |
| 國立成功大學 |
2021 |
Treatment with angiotensin receptor neprilysin inhibitor for Taiwan heart failure patients: Rationale and baseline characteristics of the TAROT-HF study
|
Lin, W.-Y.;Chung, F.-P.;Liao, C.-T.;Huang, J.-L.;Liang, H.-W.;Lee, Y.-H.;Lin, P.-L.;Chiou, W.-R.;Hsu, C.-Y.;Chang, H.-Y. |
| 國立成功大學 |
2021 |
The evolution of guideline-directed medical therapy among decompensated HFrEF patients in sacubitril/valsartan era: Medical expenses and clinical effectiveness
|
Liang, H.-W.;Liao, C.-T.;Lin, W.-Y.;Chung, F.-P.;Huang, J.-L.;Lee, Y.-H.;Lin, P.-L.;Chiou, W.-R.;Hsu, C.-Y.;Chang, H.-Y. |
| 臺大學術典藏 |
2020-12-30T08:47:36Z |
Everolimus-eluting bioresorbable vascular scaffold in real world practice - A single center experience
|
Kao H.-L.; Liang H.-W.; Lin Y.-H.; Hwang J.-J.; Lin M.-S.; Chiang F.-T.; Lee C.-M.; Yeh C.-F.; Wang T.-D.; Wu C.-K.; Lin L.-Y.; CHIA-TI TSAI; Chen Y.-H. |
| 臺大學術典藏 |
2020-12-28T12:03:51Z |
Everolimus-eluting bioresorbable vascular scaffold in real world practice - A single center experience
|
Chen Y.-H.; Tsai C.-T.; Lin L.-Y.; Wu C.-K.; Lee C.-M.; Yeh C.-F.; Wang T.-D.; Chiang F.-T.; Lin M.-S.; HWANG, JUEY-JEN; Lin Y.-H.; Kao H.-L.; Liang H.-W. |
| 臺大學術典藏 |
2020-12-28T09:31:18Z |
Everolimus-eluting bioresorbable vascular scaffold in real world practice - A single center experience
|
Yeh C.-F.; Lee C.-M.; Chiang F.-T.; Lin M.-S.; Hwang J.-J.; Lin Y.-H.; Kao H.-L.; Liang H.-W.; Wang T.-D.; Wu C.-K.; Lin L.-Y.; Tsai C.-T.; YING-HSIEN CHEN |
| 臺大學術典藏 |
2020-12-25T08:38:37Z |
Everolimus-eluting bioresorbable vascular scaffold in real world practice - A single center experience
|
Yeh C.-F.; Wang T.-D.; Wu C.-K.; Lin L.-Y.; Tsai C.-T.; Chen Y.-H.; Liang H.-W.; HSIEN-LI KAO; Lin Y.-H.; Hwang J.-J.; Lin M.-S.; Chiang F.-T.; Lee C.-M. |
| 臺大學術典藏 |
2020-12-18T07:26:27Z |
Everolimus-eluting bioresorbable vascular scaffold in real world practice - A single center experience
|
Yeh C.-F.; Wang T.-D.; Wu C.-K.; Lin L.-Y.; Tsai C.-T.; Chen Y.-H.; Liang H.-W.; Kao H.-L.; Lin Y.-H.; Hwang J.-J.; MAO-HSIN LIN; Chiang F.-T.; Lee C.-M. |
| 臺大學術典藏 |
2020-12-18T05:20:43Z |
Everolimus-eluting bioresorbable vascular scaffold in real world practice - A single center experience
|
Liang H.-W.; Kao H.-L.; YEN-HUNG LIN; Hwang J.-J.; Lin M.-S.; Chiang F.-T.; Lee C.-M.; Yeh C.-F.; Wang T.-D.; Wu C.-K.; Lin L.-Y.; Tsai C.-T.; Chen Y.-H. |
| 臺大學術典藏 |
2020-12-04T07:44:45Z |
Everolimus-eluting bioresorbable vascular scaffold in real world practice - A single center experience
|
Chen Y.-H.; Tsai C.-T.; LIAN-YU LIN; Wu C.-K.; Wang T.-D.; Yeh C.-F.; Lee C.-M.; Chiang F.-T.; Liang H.-W.; Kao H.-L.; Lin Y.-H.; Hwang J.-J.; Lin M.-S. |
